International Seaways Reports First Quarter 2025 Results
NEW YORK–(BUSINESS WIRE)–International Seaways, Inc. (NYSE: INSW) (the “Company,” “Seaways,” or “INSW”), one of the largest tanker companies... Read more.
Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto
Merck Animal Health unveils its largest economic development project in recent history RAHWAY, N.J.–(BUSINESS WIRE)–Merck Animal Health, known as MSD... Read more.
US Foods Reports First Quarter Fiscal Year 2025 Earnings
Grew Net Sales 4.5% to $9.4 Billion and Net Income 40.2% to $115 Million Grew Adjusted EBITDA 9.3% to $389 Million and Adjusted EPS 25.9% to $0.68 Reaffirms Full... Read more.
LumiThera’s LIGHTSITE IIIB Extension Trial Topline Results Show Extended Vision Improvement in Dry AMD Subjects
SEATTLE–(BUSINESS WIRE)–#DryAMD–LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease,... Read more.
Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025
PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic... Read more.
Spectrum Brands Holdings Reports Fiscal 2025 Second Quarter Results
Net Sales Decreased 6.0% and Organic Sales Decreased 4.6%, Driven Primarily by Softening North American Demand in Global Pet Care, Timing of Retailer Seasonal Inventory... Read more.
ALLETE, Inc. Reports First Quarter 2025 Earnings
DULUTH, Minn.–(BUSINESS WIRE)–ALLETE, Inc. (NYSE: ALE) today reported first quarter 2025 earnings of 97 cents per share on net income of $56.1 million.... Read more.
NCR Voyix Reports First Quarter 2025 Results
ATLANTA–(BUSINESS WIRE)–NCR Voyix Corporation (NYSE: VYX) (“NCR Voyix” or the “Company”), a leading global provider of digital commerce solutions,... Read more.
Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights
Highlights: 6-week top-line data from Part A of COMP005 phase 3 trial in treatment resistant depression on track for late June Phase 3 COMP006 in TRD on track for... Read more.
Owens & Minor Reports First Quarter 2025 Financial Results
Top-Line Growth Led by the Patient Direct Segment Patient Direct Operating Margin Expanded by 173 Basis Points Company Reaffirmed 2025 Financial Guidance Remain... Read more.